Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Arcus Biosciences
RCUS
$3.43B
| $1.95M | ﹤0.01% |
55,810
+49,753
| +821% | +$1.55M |
|
2377
Axcelis
ACLS
$3.94B
| $1.94M | ﹤0.01% |
41,331
+10,089
| +32% | +$439K |
|
2378
CNA Financial
CNA
$14.6B
| $1.94M | ﹤0.01% |
46,240
+36,143
| +358% | +$1.58M |
|
|
NGD
2379
DELISTED
New Gold Inc
NGD
| $1.94M | ﹤0.01% |
1,829,281
+601,903
| +49% | +$828K |
|
2380
PUT
Axsome Therapeutics
AXSM
$10.9B
| $1.94M | ﹤0.01% |
58,800
+8,800
| +18% | +$343K |
|
2381
Rush Enterprises Class A
RUSHA
$6.34B
| $1.94M | ﹤0.01% |
64,375
+5,598
| +10% | +$166K |
|
2382
Vanguard Long-Term Bond ETF
BLV
$5.71B
| $1.93M | ﹤0.01% |
+18,866
| New | +$1.98M |
|
2383
Forward Air
FWRD
$456M
| $1.93M | ﹤0.01% |
23,205
+5,503
| +31% | +$481K |
|
|
AXNX
2384
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.92M | ﹤0.01% |
29,443
+20,127
| +216% | +$1.37M |
|
2385
Unilever
UL
$138B
| $1.91M | ﹤0.01% |
31,358
-63,074
| -67% | -$4.02M |
|
|
ARI
2386
Apollo Commercial Real Estate
ARI
$884M
| $1.91M | ﹤0.01% |
128,921
+53,834
| +72% | +$823K |
|
2387
NBT Bancorp
NBTB
$2.77B
| $1.91M | ﹤0.01% |
52,796
-7,224
| -12% | -$254K |
|
2388
Protolabs
PRLB
$1.9B
| $1.9M | ﹤0.01% |
28,586
+9,770
| +52% | +$763K |
|
|
HUYA
2389
Huya Inc
HUYA
$579M
| $1.9M | ﹤0.01% |
228,124
+75,936
| +50% | +$877K |
|
2390
CALL
Transocean
RIG
$5.69B
| $1.9M | ﹤0.01% |
500,000
| – | – |
|
|
DSPG
2391
DELISTED
DSP Group Inc
DSPG
| $1.9M | ﹤0.01% |
86,514
+71,705
| +484% | +$1.28M |
|
2392
Usana Health Sciences
USNA
$425M
| $1.89M | ﹤0.01% |
20,537
+4,705
| +30% | +$453K |
|
|
SA
2393
Seabridge Gold
SA
$2.75B
| $1.89M | ﹤0.01% |
122,501
-18,555
| -13% | -$321K |
|
2394
Gray Television
GTN
$440M
| $1.89M | ﹤0.01% |
82,928
+22,806
| +38% | +$505K |
|
2395
US Global Jets ETF
JETS
$803M
| $1.89M | ﹤0.01% |
79,813
-77,622
| -49% | -$1.79M |
|
2396
PUT
Kinross Gold
KGC
$27.3B
| $1.88M | ﹤0.01% |
350,000
| – | – |
|
2397
Smith & Nephew
SNN
$13.8B
| $1.87M | ﹤0.01% |
54,485
+29,953
| +122% | +$1.18M |
|
2398
Evolent Health
EVH
$366M
| $1.87M | ﹤0.01% |
60,262
+35,308
| +141% | +$848K |
|
|
TGH
2399
DELISTED
Textainer Group Holdings limited
TGH
| $1.86M | ﹤0.01% |
53,420
+22,073
| +70% | +$722K |
|
|
B
2400
DELISTED
Barnes Group Inc.
B
| $1.86M | ﹤0.01% |
44,575
+19,485
| +78% | +$928K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.